These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37435034)

  • 1. Sequence Analysis of Hot Spot Regions of Spike and RNA-dependent-RNA polymerase (RdRp) Genes of SARS-CoV-2 in Kerman, Iran.
    Arefinia N; Yaghobi R; Ramezani A; Sarvari J
    Mediterr J Hematol Infect Dis; 2023; 15(1):e2023042. PubMed ID: 37435034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM; Al-Hemaid F; Sami H
    J King Saud Univ Sci; 2022 Feb; 34(2):101773. PubMed ID: 34955621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.
    Tsai MS; Shih WT; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
    Biomed Pharmacother; 2022 May; 149():112802. PubMed ID: 35279013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
    Tsai MS; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
    Biomed Pharmacother; 2021 Oct; 142():112011. PubMed ID: 34388530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding.
    Hoter A; Naim HY
    Front Mol Biosci; 2022; 9():893843. PubMed ID: 35677879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations.
    Wu J; Zhang HX; Zhang J
    Phys Chem Chem Phys; 2023 Jan; 25(3):2304-2319. PubMed ID: 36597957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.
    Augusto G; Mohsen MO; Zinkhan S; Liu X; Vogel M; Bachmann MF
    Allergy; 2022 Jan; 77(1):111-117. PubMed ID: 34453338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the receptor-binding domain of human SARS CoV-2 spike protein increases its affinity to bind human ACE-2 receptor.
    Naresh GKRS; Guruprasad L
    J Biomol Struct Dyn; 2023 Apr; 41(6):2368-2381. PubMed ID: 35109768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study).
    Hajizadeh F; Khanizadeh S; Khodadadi H; Mokhayeri Y; Ajorloo M; Malekshahi A; Heydari E
    Microb Pathog; 2022 Jul; 168():105595. PubMed ID: 35597364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical Fitness Landscape of the SARS-CoV-2 Delta Variant Receptor Binding Domain.
    Patrick C; Upadhyay V; Lucas A; Mallela KMG
    J Mol Biol; 2022 Jul; 434(13):167622. PubMed ID: 35533762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity.
    Teng S; Sobitan A; Rhoades R; Liu D; Tang Q
    Brief Bioinform; 2021 Mar; 22(2):1239-1253. PubMed ID: 33006605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of SARS-CoV-2 Delta variant isolated from Makassar, South Sulawesi, Indonesia.
    Massi MN; Sjahril R; Halik H; Soraya GV; Hidayah N; Pratama MY; Faruk M; Handayani I; Gazali FM; Hakim MS; Wibawa T
    Heliyon; 2023 Feb; 9(2):e13382. PubMed ID: 36744069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis.
    Kumar R; Srivastava Y; Muthuramalingam P; Singh SK; Verma G; Tiwari S; Tandel N; Beura SK; Panigrahi AR; Maji S; Sharma P; Rai PK; Prajapati DK; Shin H; Tyagi RK
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense mutations in spike protein of SARS-CoV-2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor.
    Mahmood TB; Hossan MI; Mahmud S; Shimu MSS; Alam MJ; Bhuyan MMR; Emran TB
    Immun Inflamm Dis; 2022 Sep; 10(9):e683. PubMed ID: 36039645
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pandey AK; Verma S
    Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Structural Analysis of Human ACE2 Receptor with Spike Protein of SARS-CoV-2 Variants: Implications to Understand Infectivity of the Virus.
    Koley T; Goswami A; Kumar M; Upadhyay N; Hariprasad G
    Adv Appl Bioinform Chem; 2022; 15():21-27. PubMed ID: 35734581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface.
    Ali N; Khan R; AlAsmari AF; Kumar V
    Process Biochem; 2022 Apr; 115():70-79. PubMed ID: 35194375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.